---
title: News | Controlled Drugs | Abuse Potential | Scitegrity (2)
description: Scitegrity provides the latest News for Controlled Drugs and Abuse Potential from around the world. Click here for up-to-date industry updates. (2)
---

[![Scitegrity](https://blog.scitegrity.com/hubfs/raw_assets/public/scitegrity/images/logo.svg)](https://www.scitegrity.com?hsLang=en-gb)

- Solutions 
    - [Controlled & Regulated Chemicals](https://www.scitegrity.com/controlled-substances)
    - [Drug Abuse Potential](https://www.scitegrity.com/drug-abuse)
    - [Tariff Coding for Chemicals](https://www.scitegrity.com/expedichem)
    - [Dangerous Goods Assessment](https://www.scitegrity.com/en-gb/dangerous-goods)
    - [Compliance Hub](https://www.scitegrity.com/compliance-hub)
- [Resources](https://blog.scitegrity.com/resources)
- [About](https://www.scitegrity.com/about) 
    - [Scitegrity](https://www.scitegrity.com/about)
    - [Testimonials](https://www.scitegrity.com/customer-testimonials)
    - [Our Partners](https://www.scitegrity.com/partners)
- [News](https://blog.scitegrity.com/news)

[Request Demo](https://www.scitegrity.com/demo-request?hsLang=en-gb)

# Scitegrity **News**

## The **latest**

- [Controlled drugs](https://blog.scitegrity.com/news/tag/controlled-drugs)
- [Shipping](https://blog.scitegrity.com/news/tag/shipping)
- [Abuse Potential](https://blog.scitegrity.com/news/tag/abuse-potential)
- [Dangerous Chemicals](https://blog.scitegrity.com/news/tag/dangerous-chemicals)

### [![](https://blog.scitegrity.com/hubfs/rendered2.jpg) 29 April 2026 Controlled Substances Squared for global compliance](https://blog.scitegrity.com/news/controlled-substances-squared-for-global-compliance)

### [![](https://blog.scitegrity.com/hubfs/RegulatoryRoundup.png) 7 April 2026 DEA updates March 2026](https://blog.scitegrity.com/news/dea-updates-march-2026)

### [![Phenyethylamine](https://blog.scitegrity.com/hubfs/Phenylalkylamine.png) 7 April 2026 Switzerland add 3 new generic statements](https://blog.scitegrity.com/news/switzerland-add-3-new-generic-statements)

### [![](https://blog.scitegrity.com/hubfs/RegulatoryRoundup.png) 7 April 2026 Denmark consolidates and updates legislationpic substances lists with dozens of chemicals, and schedule changes (Clone)](https://blog.scitegrity.com/news/denmarkconsolidation2026)

### [![](https://blog.scitegrity.com/hubfs/RegulatoryRoundup.png) 29 January 2026 Belgium updates narcotic and psychotropic substances lists with dozens of chemicals, and schedule changes](https://blog.scitegrity.com/news/belgium-controlled-drug-updates-2026)

### [![](https://blog.scitegrity.com/hubfs/DEA%20logo.jpg) 29 January 2026 DEA ammends regulations on “cannabimimetic agents”.](https://blog.scitegrity.com/news/dea-cannabimimetic-agents)

### [![Flags of the world](https://blog.scitegrity.com/hubfs/flags.jpg) 9 December 2025 New EU regulations on drug precursors](https://blog.scitegrity.com/news/new-eu-regulations-on-drug-precursors)

### [![](https://blog.scitegrity.com/hubfs/Deutetrabenazine.png) 22 October 2025 Deuterated chemicals in R&D and drugs](https://blog.scitegrity.com/news/deuterated-chemicals)

<https://blog.scitegrity.com/news/page/1> [1](https://blog.scitegrity.com/news/page/1) [2](https://blog.scitegrity.com/news/page/2) [3](https://blog.scitegrity.com/news/page/3) [4](https://blog.scitegrity.com/news/page/4) [5](https://blog.scitegrity.com/news/page/5) <https://blog.scitegrity.com/news/page/3>

## Trusted by our **Clients**

![cayman](https://blog.scitegrity.com/hubfs/cayman.png)

![LGC_standards-1](https://blog.scitegrity.com/hubfs/LGC_standards-1.jpg)

![Roche](https://blog.scitegrity.com/hubfs/Roche.png)

![gsk](https://blog.scitegrity.com/hubfs/gsk.png)

![Boehringer](https://blog.scitegrity.com/hubfs/Boehringer.png)

![Merck_logo](https://blog.scitegrity.com/hubfs/Merck_logo.jpg)

![HomeOffice logo](https://blog.scitegrity.com/hubfs/HomeOffice%20logo.jpg)

![sygnature_logo](https://blog.scitegrity.com/hubfs/sygnature_logo.png)

![UCB](https://blog.scitegrity.com/hubfs/UCB.png)

![AstraZeneca](https://blog.scitegrity.com/hubfs/AstraZeneca.jpg)

![Biosynth_logo_new](https://blog.scitegrity.com/hubfs/Biosynth_logo_new.png)

[![Scitegrity](https://blog.scitegrity.com/hubfs/raw_assets/public/scitegrity/images/logo.svg)](https://blog.scitegrity.com/?hsLang=en-gb)

Scitegrity Limited, Discovery Park Enterprise Zone,   
Ramsgate Road, Sandwich, Kent, CT13 9FF, UK.

- [Terms & Conditions](https://www.scitegrity.com/terms)
- [Privacy Policy](https://www.scitegrity.com/terms#privacy)
- [Cookie Policy](https://www.scitegrity.com/terms#cookies)
- [ESG policy](https://www.scitegrity.com/esg-statement)

### Connect

- <https://www.linkedin.com/company/scitegrity/>
- <https://twitter.com>

### Support

[contact@scitegrity.com](mailto:contact@scitegrity.com)

![winners+assets+2025_KAE_logo_2025_CMYK_international_trade_LOW_RES](https://blog.scitegrity.com/hs-fs/hubfs/winners+assets+2025_KAE_logo_2025_CMYK_international_trade_LOW_RES.jpg?width=154&height=155&name=winners+assets+2025_KAE_logo_2025_CMYK_international_trade_LOW_RES.jpg) 

![](https://px.ads.linkedin.com/collect/?pid=219252&fmt=gif)